Artificial Intelligence, Machine Learning, and Deep Learning in the Diagnosis and Management of Hepatocellular Carcinoma
Artificial Intelligence (AI) can be a useful tool in the management of disease processes such as hepatocellular carcinoma (HCC) as treatment decisions are often complex and multifaceted. AI applications in medicine are expanding with the ongoing advances in AI including more sophisticated machine le...
Main Authors: | Carolina Larrain, Alejandro Torres-Hernandez, Daniel Brock Hewitt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-01-01
|
Series: | Livers |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-4389/4/1/4 |
Similar Items
-
State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma
by: Anna Castaldo, et al.
Published: (2021-06-01) -
Radiomics and machine learning based on preoperative MRI for predicting extrahepatic metastasis in hepatocellular carcinoma patients treated with transarterial chemoembolization
by: Gang Peng, et al.
Published: (2024-06-01) -
Preoperative Evaluation of Hepatocellular Carcinoma Differentiation Using Contrast-Enhanced Ultrasound-Based Deep-Learning Radiomics Model
by: Qin X, et al.
Published: (2023-02-01) -
CT radiomics based on different machine learning models for classifying gross tumor volume and normal liver tissue in hepatocellular carcinoma
by: Huai-wen Zhang, et al.
Published: (2024-01-01) -
Artificial Intelligence in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review
by: Alessandro Martinino, et al.
Published: (2022-10-01)